ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Wisconsin » Neurology

Top Neurology Prescribers in Wisconsin

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
THOMAS BERENTSEN MD

Neurology

3,465

$829K

383
211 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 22%

$239
Average prescription price

Avg: $206

JOHN JONES MD

Neurology

3,400

$489K

182
79 are 65+

12%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 22%

$144
Average prescription price

Avg: $206

RICHARD HUTTER MD

Neurology

3,356

$530K

280
145 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

5%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 22%

$158
Average prescription price

Avg: $206

KRISHNA BHATT M.D.

Neurology

3,335

$562K

251
152 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 22%

$168
Average prescription price

Avg: $206

RAE HANSON MD

Neurology

3,218

$333K

155
39 are 65+

7%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 22%

$103
Average prescription price

Avg: $206

SYLVIA DENNISON MD

Neurology

3,205

$392K

166
50 are 65+

7%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 22%

$122
Average prescription price

Avg: $206

EVAN SANDOK MD

Neurology

3,089

$607K

420
166 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 22%

$197
Average prescription price

Avg: $206

XIAN GU M.D.

Neurology

3,074

$538K

395
232 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

5%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 22%

$175
Average prescription price

Avg: $206

RIZWANULLAH ARAIN M.D.

Neurology

2,922

$325K

203
45 are 65+

25%
patients receiving schedule two controlled substances

Avg: 3%

6%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

12%
prescriptions for brand name drugs

Avg: 22%

$111
Average prescription price

Avg: $206

PAUL ATKINSON M.D.

Neurology

2,901

$421K

315
192 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 22%

$145
Average prescription price

Avg: $206

BRAD BEINLICH MD

Neurology

2,821

$463K

202
74 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 22%

$164
Average prescription price

Avg: $206

GREGORY FISCHER MD

Neurology

2,794

$826K

272
130 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 22%

$296
Average prescription price

Avg: $206

ERIC POTTS M.D.

Neurology

2,788

$438K

276
174 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 22%

$157
Average prescription price

Avg: $206

MICHAEL MITCHELL MD

Neurology

2,761

$512K

371
231 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

15%
prescriptions for brand name drugs

Avg: 22%

$186
Average prescription price

Avg: $206

THOMAS ZWEIFEL D.O.

Neurology

2,758

$433K

253
177 are 65+

6%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 22%

$157
Average prescription price

Avg: $206

SCOTT VANSTEEN M.D.

Neurology

2,729

$918K

280
203 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 22%

$336
Average prescription price

Avg: $206

JANELLE COOPER MD

Neurology

2,689

$323K

359
314 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

42%
prescriptions for brand name drugs

Avg: 22%

$120
Average prescription price

Avg: $206

BRIAN CHAPMAN M.D.

Neurology

2,620

$413K

283
192 are 65+

11%
patients receiving schedule two controlled substances

Avg: 3%

7%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 22%

$158
Average prescription price

Avg: $206

HEATHER STANKO MD

Neurology

2,614

$416K

260
137 are 65+

6%
patients receiving schedule two controlled substances

Avg: 3%

7%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 22%

$159
Average prescription price

Avg: $206

KRZYSZTOF GOETZEN MD

Neurology

2,614

$256K

282
159 are 65+

9%
patients receiving schedule two controlled substances

Avg: 3%

24%
patients receiving schedule three controlled substances

Avg: 2%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

13%
prescriptions for brand name drugs

Avg: 22%

$98
Average prescription price

Avg: $206

CHRISTOPHER BIXLER MD

Neurology

2,552

$620K

287
161 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 22%

$243
Average prescription price

Avg: $206

JAIME BOERO MD PHD

Neurology

2,550

$340K

302
187 are 65+

25%
patients receiving schedule two controlled substances

Avg: 3%

7%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

14%
prescriptions for brand name drugs

Avg: 22%

$133
Average prescription price

Avg: $206

CHRISTOPHER LUZZIO MD

Neurology

2,537

$1.8M

179
58 are 65+

10%
patients receiving schedule two controlled substances

Avg: 3%

11%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 22%

$709
Average prescription price

Avg: $206

NAOMI ARENSON MD

Neurology

2,530

$491K

245
108 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 22%

$194
Average prescription price

Avg: $206

LAURA BUYAN DENT M.D.

Neurology

2,513

$355K

246
183 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 22%

$141
Average prescription price

Avg: $206

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank